Novo Holdings leads Therachon's $60M round

Rare disease company Therachon AG (Basel, Switzerland) said on Aug. 9 it completed a $60 million mezzanine financing led by new investor Novo Holdings.

Fellow new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management participated, as did existing investors Versant Ventures, OrbiMed, Bpifrance and Inserm Transfert Initiative...